Assessment of Reinjection Numbers and Intervals for Diabetic Macular Edema Patients Who Received Dexamethasone Intravitreal Implants in Germany and Switzerland

QR Code

Assessment of Reinjection Numbers and Intervals for Diabetic Macular Edema Patients Who Received Dexamethasone Intravitreal Implants in Germany and Switzerland

Albert J Augustin,1 Matthias D Becker,2,3 Katja Hatz,4 Hakan Kaymak,5 Andrew Shirlaw6 1Eye Care Clinic, Karlsruhe, Germany; 2Department of Ophthalmology, Zurich City Hospital, Zurich, Switzerland; 3Department of Ophthalmology, University of Heidelberg, Heidelberg, Germany; 4Vista Klinik Binningen, S...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Augustin AJ, Becker MD, Hatz K, Kaymak H, Shirlaw A
Format:	article
Langue:	EN
Publié:	Dove Medical Press 2021
Sujets:	diabetic macular edema dme real-world setting safety drug effectiveness Ophthalmology RE1-994
Accès en ligne:	https://doaj.org/article/c4a4f13f06b748afa25c5f624f49d2cd
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Contralateral eye-to-eye comparison of intravitreal ranibizumab and a sustained-release dexamethasone intravitreal implant in recalcitrant diabetic macular edema
par: Thomas BJ, et autres
Publié: (2016)

Relationship between aqueous humor cytokine level changes and retinal vascular changes after intravitreal aflibercept for diabetic macular edema
par: Rodolfo Mastropasqua, et autres
Publié: (2018)

Clinical-Decision Criteria to Identify Recurrent Diabetic Macular Edema Patients Suitable for Fluocinolone Acetonide Implant Therapy (ILUVIEN®) and Follow-Up Considerations/Recommendations
par: Adán A, et autres
Publié: (2020)

Real-World Outcomes in Diabetic Macular Edema for the 0.2 μg/Day Fluocinolone Acetonide Implant: Case Series from the Midlands, UK
par: Mushtaq B, et autres
Publié: (2021)

Update on corticosteroids for diabetic macular edema
par: Schwartz SG, et autres
Publié: (2016)

Treatment of refractory uveitic macular edema: results of a first and second implant of long-acting intravitreal dexamethasone
par: Zola M, et autres
Publié: (2017)

Cost-Effectiveness of Conbercept vs. Ranibizumab for Age-Related Macular Degeneration, Diabetic Macular Edema, and Pathological Myopia: Population-Based Cohort Study and Markov Model
par: Zhuang Cui, et autres
Publié: (2021)

Intravitreal aflibercept versus intravitreal ranibizumab for the treatment of diabetic macular edema
par: Fouda SM, et autres
Publié: (2017)

Oral kallidinogenase improved visual acuity and maintained chorioretinal blood flow levels after treatment for diabetic macular edema
par: Tsuiki E, et autres
Publié: (2018)

Topical NSAIDs, intravitreal dexamethasone and peribulbar triamcinolone for pseudophakic macular edema
par: Javier Obis, et autres
Publié: (2021)

Intravitreal pegaptanib for the treatment of ischemic diabetic macular edema
par: Kiire CA, et autres
Publié: (2015)

Intravitreal bevacizumab injections versus dexamethasone implant for treatment-naïve retinal vein occlusion related macular edema
par: Laine I, et autres
Publié: (2017)

Dexamethasone implant in the management of diabetic macular edema from clinician’s perspective
par: Urbančič M, et autres
Publié: (2019)

Intravitreal bevacizumab injections for diabetic macular edema – predictors of response: a retrospective study
par: Joshi L, et autres
Publié: (2016)

Letter to the Editor Regarding the “Effectiveness of 190 μg Fluocinolone Acetonide and 700 μg Dexamethasone Intravitreal Implants in Diabetic Macular Edema Using the Area-Under-the-Curve Method: The Constant Analysis” Article [Letter]
par: Taylor K, et autres
Publié: (2020)

EFFECT OF INTRAVITREAL TRIAMCINOLONE ACETONIDE IN REFRACTORY DIABETIC MACULAR EDEMA
par: Ume Sughra, et autres
Publié: (2021)

Pseudophakic cystoid macular edema: update 2016
par: Grzybowski A, et autres
Publié: (2016)

Impact of Different Clinical Baseline Characteristics on Intravitreal Dexamethasone Implant Ozurdex® Outcomes
par: Udaondo P, et autres
Publié: (2021)

Intravitreal ziv-aflibercept for macular edema following retinal vein occlusion
par: Paulose R, et autres
Publié: (2016)

One-Year Outcome of Aflibercept Intravitreal Injection in Vitrectomized Eyes with Diabetic Macular Edema
par: Tran THC, et autres
Publié: (2021)

Intravitreal Ranibizumab or Aflibercept After Bevacizumab in Diabetic Macular Edema: Exploratory Retrospective Analysis
par: Pessoa B, et autres
Publié: (2021)

Macular edema resolution assessment with implantable dexamethasone in diabetic retinopathy (MERIT): a pilot study
par: Chhablani J, et autres
Publié: (2018)

The outcome of low-frequency intravitreal bevacizumab therapy for macular edema in retinal vein occlusions
par: Ivanovska Adjievska B, et autres
Publié: (2017)

Intravitreal Aflibercept versus Laser Photocoagulation in Asian Patients with Diabetic Macular Edema: The VIVID-East Study
par: Chen YX, et autres
Publié: (2020)

Short-term outcomes in patients with branch retinal vein occlusion who received intravitreal aflibercept with or without intravitreal ranibizumab
par: Sakanishi Y, et autres
Publié: (2017)

Real-world retrospective comparison of 0.19 mg fluocinolone acetonide and 0.7 mg dexamethasone intravitreal implants for the treatment of diabetic macular edema in vitrectomized eyes
par: Coelho J, et autres
Publié: (2019)

Treatment of Macular Edema in Vascular Retinal Diseases: A 2021 Update
par: Andrzej Grzybowski, et autres
Publié: (2021)

Clinical therapeutic effects of intravitreal injection of Conbercept for macular edema in different types of retinal vein occlusion
par: Peng-Yao Lin, et autres
Publié: (2021)

EFFECT OF ANTI-VEGF THERAPY ON THE STRUCTURAL STATE OF THE RETINA IN DIABETIC MACULAR EDEMA
par: M. M. Bikbov, et autres
Publié: (2016)

Long-term results of combination therapy using anti-VEGF agents and dexamethasone intravitreal implant for retinal vein occlusion: an investigational case series
par: Singer MA, et autres
Publié: (2016)

Effect of oral tranexamic acid on macular edema associated with retinal vein occlusion or diabetes
par: Takeyama M, et autres
Publié: (2017)

Clinical utility of intravitreal fluocinolone acetonide (Iluvien®) implant in the management of patients with chronic diabetic macular edema: a review of the current literature
par: Saedon H, et autres
Publié: (2017)

Evaluation Of The Timing Of Intravitreal Bevacizumab Injection As Adjuvant Therapy To Panretinal Photocoagulation In Patients With Diabetic Macular Edema Secondary To Diabetic Retinopathy
par: Kartasasmita A, et autres
Publié: (2019)

Multicenter, Prospective, Randomized Study of Dexamethasone Intravitreal Implant in Patients with Center-Involved Diabetic Macular Edema in the Asia-Pacific Region
par: Wei W, et autres
Publié: (2021)

Primary treatment of diabetic macular edema
par: Tushar M Ranchod, et autres
Publié: (2009)

Choroidal Blood Flow After Intravitreal Ranibizumab in Vitrectomized and Non-Vitrectomized Eyes with Diabetic Macular Edema
par: Pessoa B, et autres
Publié: (2021)

Analysis of Funding Source and Spin in the Reporting of Studies of Intravitreal Corticosteroid Therapy for Diabetic Macular Edema: A Systematic Review
par: Nithianandan H, et autres
Publié: (2020)

Initial Ten Years of Experience with the Intravitreal Dexamethasone Implant: A Retrospective Chart Review
par: Wallsh J, et autres
Publié: (2020)

Evaluation of the effectiveness and safety of glucocorticoids intravitreal implant therapy in macular edema due to retinal vein occlusion
par: Michalska-Małecka K, et autres
Publié: (2016)

Effectiveness of 190 μg Fluocinolone Acetonide and 700 μg Dexamethasone Intravitreal Implants in Diabetic Macular Edema Using the Area-Under-the-Curve Method: The CONSTANT Analysis
par: Zarranz-Ventura J, et autres
Publié: (2020)